EUVIMEDEUVIMED entdecken
Crossref

Effect of Migraine Abortive Drugs on Benign Paroxysmal Positional Vertigo Odds: A Database Analysis

Marwin Li, Marwin Li, Claire Ceriani, Hongyan Li

Audiology and Neurotology · 2025

DOI: 10.1159/000545977 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Audiology and Neurotology, 2025. Verfasst von Marwin Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Migraine Disorders, Benign Paroxysmal Positional Vertigo, Tryptamines, Calcitonin Gene-Related Peptide Receptor Antagonists. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients with migraine may be more susceptible to benign paroxysmal positional vertigo (BPPV) than the general population. Although the underlying pathophysiology remains uncertain, it has been postulated that recurrent vasospasms associated with migraine attacks may cause inner ear ischemia and changes in endolymph pressure. Currently, there are no specific recommendations for preventing BPPV in this vulnerable patient population. Among commonly used migraine abortive drugs, triptans, which are selective serotonin agonists, are known to be vasoconstrictive, whereas calcitonin gene-related peptide (CGRP) antagonists are not. This population-based study uses a federated electronic medical record (EMR) database to characterize the prevalence of BPPV among migraine patients and its relevance to their choice of abortive drug.

Methods

In this case-control study, EMR data from the TriNetX US Collaborative Network were queried for subjects who were seen at a participating healthcare organization for a vestibular disorder (ICD10: H81) between 2019 and 2024. Subjects must also have a concomitant, pre-existing diagnosis of migraine (G43). These patients were stratified by age (18–44, 45–64, 65+ years) and sex. The resulting cohorts were then divided into those with and without a BPPV diagnosis (H81.1). Patients with prior documented head trauma (S02, S06, S09), middle or inner ear surgery, or vitamin D deficiency (E55) were excluded. The prevalence of pre-existing triptan and CGRP antagonist use of each BPPV cohort was compared against the non-BPPV cohort of the same age and sex using χ2 analysis.

Results

As expected, the female subject population had significantly higher prevalence of migraine (17.06% vs. 7.26%, p < 0.0001) than the males. Among migraine patients of all ages and sexes, triptan use was significantly more common among BPPV patients than non-BPPV patients (30.90% vs. 25.35%, p < 0.0001). Conversely, CGRP antagonists were more commonly used by non-BPPV patients than by BPPV patients (3.17% vs. 2.45%, p = 0.0005).

Conclusion

This study shows that, among patients with vestibular disorders, migraine patients with BPPV are more often exposed to triptans, and less to CGRP antagonists, than those without BPPV. Triptans may increase the prevalence of BPPV by potentiating vasoconstriction during migraine attacks, which may result in inner ear ischemia and alterations of endolymphatic pressure, while CGRP antagonists do not. Therefore, CGRP antagonists may be preferable over triptans for preventing BPPV in migraine patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersBenign Paroxysmal Positional VertigoTryptaminesCalcitonin Gene-Related Peptide Receptor AntagonistsHumansFemaleMaleMiddle AgedAdultAgedCase-Control StudiesDatabases, FactualYoung AdultAdolescentPrevalence

Stichwörter der Autor:innen

Abortive drugsBenign paroxysmal positional vertigoCalcitonin gene-related peptide antagonistMigraineTriptan

Substanzen

TryptaminesCalcitonin Gene-Related Peptide Receptor Antagonists

Autor:innen und Institutionen

  • Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA.
  • Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
  • Department of Neurology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.

Zitieren

APA

Li, M., Li, M., Ceriani, C., & Li, H. (2025). Effect of Migraine Abortive Drugs on Benign Paroxysmal Positional Vertigo Odds: A Database Analysis. Audiology and Neurotology. https://doi.org/10.1159/000545977

Vancouver

Li M, Li M, Ceriani C, Li H. Effect of Migraine Abortive Drugs on Benign Paroxysmal Positional Vertigo Odds: A Database Analysis. Audiology and Neurotology. 2025. doi:10.1159/000545977

BibTeX
@article{Li2025,
  author = {Li, Marwin and Li, Marwin and Ceriani, Claire and Li, Hongyan},
  title = {Effect of Migraine Abortive Drugs on Benign Paroxysmal Positional Vertigo Odds: A Database Analysis},
  journal = {Audiology and Neurotology},
  year = {2025},
  doi = {10.1159/000545977}
}
Kostenlos starten →